Ho-ho-ho! Gather ’round, my curious elves, for a tale of modern alchemy where the magic of nature meets the wizardry of science in the battle against a most formidable foe—cancer. In the land of clinical treatment, there’s been quite the buzz about a powerful spell known as immune checkpoint blockade, a charm that can unmask cancer cells to the vigilant warriors of the immune system.

Now, the cleverest of researchers, much like the elves in my workshop, have been toiling away, not with toys, but with concoctions of immune checkpoint inhibitors mixed with other potions to outwit the cancerous Grinch. And what might these other potions be, you ask? Why, phytochemicals, of course! These little helpers, plucked from the gardens of vegetables and fruits, are not just for a healthy snack on Christmas Eve; they pack a punch with their antiproliferative, proapoptotic, and antiangiogenic effects, which in the common tongue means they’re quite good at thwarting cancer’s naughty tricks.

But wait, there’s more! These phytochemicals, much like the elves who adjust their strategies to pack the sleigh just right, modulate the tumor microenvironment, tweaking T cells and cytokines to create a less hospitable winter wonderland for tumors.

In tales of recent yore, several phytochemicals have been whispered to dance with immune checkpoint proteins, both in the test tube and in living creatures. They’ve been seen decreasing the expression of a certain mischief-maker, programmed cell death ligand-1, and when paired with the PD-1 monoclonal antibody, they synergize to suppress tumor growth, much like how Rudolph and the reindeer team up to pull my sleigh.

When these phytochemicals join forces with PD-1 monoclonal antibody, it’s like adding an extra dash of Christmas magic, enhancing tumor growth inhibition and inviting more CD4⁺ and CD8⁺ T-cell elves to the party.

In this review, we’ll embark on a sleigh ride through the realm of immune checkpoint molecules, exploring them as potential therapeutic targets for cancers. We’ll also delve into the enchanting world of phytochemicals—carotenoids, polyphenols, saponins, and organosulfur compounds—and their interactions with cancer PD-1/programmed cell death ligand-1 immune checkpoint molecules. And, of course, we’ll document their combined effects with immune checkpoint inhibitors on various malignancies, much like how we document who’s been naughty or nice.

So, fasten your seatbelts, my dear elves, for this sleigh ride through the snowy peaks of science and nature, where together, we may just find the key to a cancer-free world! 🎅🔬🍎